Pediatric systemic lupus erythematosus: more than a positive antinuclear antibody.
Based on strong research evidence and consensus, the most common disease manifestations at diagnosis of pSLE are constitutional symptoms, arthritis, and malar rash. Based on some research evidence and consensus, patients with pSLE tend to have major organ system involvement (renal/central nervous system) and a greater disease burden compared with adults. Despite these findings, mortality is low. Based on some research evidence and consensus, the diagnosis of pSLE is unlikely if the ANA is negative, and most patients with SLE have a positive ANA at a titer ≥1:160. Based on strong research evidence, both MMF and cyclophosphamide can be used for induction therapy in class III and IV lupus nephritis. Based on strong research evidence, patients with SLE and anticardiolipin antibodies or LA have a two and six times greater risk of venous thrombosis, respectively, compared with patients with SLE without antiphospholipid antibodies. Based on strong research evidence, patients with pSLE have a higher risk for subclinical atherosclerosis when there is weight-adjusted prednisone use, azathioprine use, increasing age, male gender, high BMI, abnormal creatinine clearance, and elevated lipoprotein(a) levels.
University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, USA.
Jennifer E
JE
Weiss
D000974:Antibodies, Antinuclear / Q000276:immunology; D002648:Child; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000145:classification / Q000150:complications / Q000151:congenital / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D009140:Musculoskeletal Diseases / Q000209:etiology / Q000276:immunology
D000974:Antibodies, Antinuclear; D005938:Glucocorticoids